explore -WSS

explore

author：comprehensive 2025-08-19 12:10:25 - browse：6746

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Antibody drugs appear effective. Now can we make enough of them?

Wikipedia

WSS

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

How to save health care price transparency rules

Steward Health Care Massachusetts hospitals face fiscal disaster

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

entertainment

explore

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

How many hemophilia patients actually want gene therapy?

Virginia high school admissions case could be legal follow

First U.S. drug developed to treat liver disease MASH is approved

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Antibody drugs appear effective. Now can we make enough of them?

The cancer drug shortage isn’t new — and neither are the solutions

Male and female sex labels in research insufficient, scientists say

Dobbs anniversary: the lost opportunity of abortion as health care

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

leisure time

Blinken talks high

Boston's new lab space is opening empty

RaDonda Vaught links Vanderbilt hospital issues to patient death

Boston's new lab space is opening empty

HHS secretary Becerra pressed on Change HealthCare cyberattack

Why depression after traumatic brain injury is distinct

explore

focus

Wikipedia

Wikipedia